Related Experiment Video
Updated: Oct 7, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Smoking as a persistent global health challenge: perspectives on heated tobacco products
Anadi Bisht1,2, Shuki3, Manish Singh4
1School of Interdisciplinary Research, Indian Institute of Technology Delhi, New Delhi, India.
Abstract:
Smoking remains one of the leading preventable causes of morbidity and mortality worldwide, significantly contributing to the healthcare burden. Despite decades of public awareness, many people are unable to quit combustible cigarette (CC) smoking due to nicotine dependence and/or limited access to effective cessation support. Various alternative tobacco products such as e-cigarettes, heated tobacco products (HTPs) and nicotine pouches have been promoted as lesser harm alternatives; among which HTPs have received increasing attention lately. However, these products differ substantially in their composition, patterns of use, and potential health effects. This narrative review evaluates evidence on HTPs relative to CCs across four distinct levels: (i) product emissions, (ii) biomarkers of human exposure, (iii) indicators and evidence relevant to individual disease risk, and (iv) potential population-health impact. These levels are considered separately because reduced emissions or exposure cannot, by itself, establish reduced clinical disease, mortality, or net population benefit. Compared to combustible cigarettes, HTPs may lessen exposure to some combustion-related toxicant, but they are not risk-free; their population-health impact depends on who takes up these products and under what social and cultural circumstances, the frequency, intensity and duration of use, exclusive versus dual or poly use, users' prior exposure and health status, and the wider institutional, infrastructural and regulatory environment. To guide effective policy formulation for harm reduction based on evidence further longitudinal epidemiological and policy-evaluation studies across diverse settings are needed to assess long-term health outcomes and determine how tobacco-control and harm-reduction strategies-including public communication and education, taxation, product regulation and cessation support-shape awareness, risk perceptions, product uptake and substitution, patterns and intensity of use, cessation and relapse.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

